October 14, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risk for leukopenia/neutropenia in patients receiving antipsychotics, including ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 10.8 mg contains the active ingredient goserelin acetate.
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 3.6 mg contains the active ingredient goserelin acetate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results